Re: And volume shoots up again...281K traded
|
3
|
Resverlogix Corp.
|
Dec 09, 2019 04:46PM
|
Re: And volume shoots up again...281K traded
|
3
|
Resverlogix Corp.
|
Dec 09, 2019 12:20PM
|
Re: And we wait.......
|
5
|
Resverlogix Corp.
|
Jan 24, 2018 07:04AM
|
Re: AND, APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE
|
3
|
Resverlogix Corp.
|
Jun 05, 2020 07:37PM
|
Re: Angiochem receives $7.5 million in Series C financing
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 03, 2018 12:50PM
|
Re: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript
|
3
|
Zenith Epigenetics
|
Jan 06, 2021 10:50AM
|
Re: Anonymous was busy into the closing bell....
|
3
|
Resverlogix Corp.
|
Feb 12, 2016 11:50AM
|
Re: Another article
|
4
|
Resverlogix Corp.
|
Nov 20, 2019 02:55PM
|
Re: Another article
|
4
|
Resverlogix Corp.
|
Nov 20, 2019 10:00PM
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
5
|
Resverlogix Corp.
|
Jan 28, 2016 12:21PM
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
2
|
Resverlogix Corp.
|
Jan 15, 2016 11:53AM
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
2
|
Resverlogix Corp.
|
Jan 28, 2016 02:36PM
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
4
|
Resverlogix Corp.
|
Jan 19, 2016 04:07PM
|
Re: Another Indication ?
|
4
|
Resverlogix Corp.
|
May 11, 2019 11:32AM
|
Re: Another possibility?
|
2
|
Zenith Epigenetics
|
Dec 10, 2015 10:20AM
|
Re: Another reason RVX can trade higher than AMRN
|
6
|
Resverlogix Corp.
|
Apr 29, 2019 12:33PM
|
Re: Another RVX-208 Poster at IAS 2015 May 26
|
5
|
Resverlogix Corp.
|
May 22, 2015 10:51AM
|
Re: Another RVX-208 Poster at IAS 2015 May 26
|
3
|
Resverlogix Corp.
|
May 18, 2015 03:49PM
|
Re: Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics
|
4
|
Resverlogix Corp.
|
Jun 12, 2017 08:00PM
|
Re: Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics
|
1
|
Resverlogix Corp.
|
Jun 12, 2017 08:24PM
|